The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
Nathan M Radcliffe Ophthalmology, New York University, New York, NY, USA Abstract: Glaucomatous optic atrophy is the second most common cause of blindness worldwide, and lowering intraocular pressure (IOP) is the only proven method to slow or stop the progression of the disease. Approximately 40%...
Main Author: | Radcliffe NM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-12-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/the-impact-of-timolol-maleate-on-the-ocular-tolerability-of-fixed-comb-peer-reviewed-article-OPTH |
Similar Items
-
Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
by: Nicholas P Bell, et al.
Published: (2010-11-01) -
Design and evaluation of guargum - based timolol maleate ocular insert For the treatment of glaucoma
by: Sunil Thakral
Published: (2015-12-01) -
A study of effectiveness and adherence between fixed combination dorzolamide /timolol maleate and non-fixed dorzolamide and timolol xe in open angle glaucoma
by: Rasid, Noor Khairul
Published: (2015) -
Effects of Latanoprost 0.005%/Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma
by: Berna Yüce, et al.
Published: (2012-01-01) -
Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension
by: Yoshikawa K, et al.
Published: (2014-02-01)